Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cell And Gene Therapy Clinical Trial Services Global Market Report 2025
Request Sample Buy Now
Global Cell And Gene Therapy Clinical Trial Services Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cell And Gene Therapy Clinical Trial Services Global Market Report 2025

By Service (Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services), By Therapy Type (Gene Therapy, Cell Therapy, Gene Modified Cell Therapy), By Indication (Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications), By End-Use (Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cell And Gene Therapy Clinical Trial Services Market Overview

• Cell And Gene Therapy Clinical Trial Services market size has reached to $3.79 billion in 2024

• Expected to grow to $6.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%

• Growth Driver: Role Of Cell And Gene Therapy Trials In Tackling Genetic Diseases

• Market Trend: Innovative Solutions In Cell And Gene Therapy Clinical Trial Services Market

• North America was the largest region in 2024.

What Is Covered Under Cell And Gene Therapy Clinical Trial Services Market?

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards.

The main types of cell and gene therapy clinical trial services include clinical trial design and planning, supply and logistic services, regulatory affairs and compliance, data management and biostatics, site management and monitoring, and others. Clinical trial design and planning involve creating and organizing the blueprint for clinical trials, deciding what the trial will test, and how IT will be conducted. Several types of therapies are included, such as gene therapy, cell therapy, and gene-modified cell therapy, which are used for various indications, such as oncology, hematology, metabolic disorders, infectious diseases, neurology, cardiovascular diseases, musculoskeletal disorders, and others. These are used by various end-users, including pharmaceutical and biotechnology companies, contract research organizations, academic and research institutes, and others.

Cell And Gene Therapy Clinical Trial Services Market Size and growth rate 2025 to 2029: Graph

What Is The Cell And Gene Therapy Clinical Trial Services Market Size 2025 And Growth Rate?

The cell and gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $3.79 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for effective treatments for rare genetic disorders, increased government funding for research in regenerative medicine, increased understanding of molecular mechanisms underlying various diseases, and increased awareness of the potential of personalized medicine.

What Is The Cell And Gene Therapy Clinical Trial Services Market Growth Forecast?

The cell and gene therapy clinical trial services market size is expected to see rapid growth in the next few years. It will grow to $6.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing global incidence of genetic and auto-immune diseases, rising public and private sector funding for gene therapy research, growing adoption of novel technologies, and a rise in the number of genetic defects. Major trends in the forecast period include the adoption of AI, the adoption of machine learning, the adoption of personalized medicine, technological advancements, and gene therapies.

The forecast of 9.5% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. trial sponsors by driving up the cost of specialized monitoring services and potency assays sourced from Belgium and Japan, exacerbating already high development costs for breakthrough therapies. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Cell And Gene Therapy Clinical Trial Services Market Segmented?

1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services

2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy

3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications

4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users

Subsegments:

1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans

2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services

3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)

4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions

5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring

6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection

What Is Driving The Cell And Gene Therapy Clinical Trial Services Market? Role Of Cell And Gene Therapy Trials In Tackling Genetic Diseases

The rising incidence of genetic disease is expected to propel the growth of the cell and gene therapy clinical trial services market going forward. Genetic diseases are ailments caused by variations in a person's DNA or genetic composition. The incidence of genetic diseases is on the rise due to numerous factors, including the increased availability of genetic testing, the occurrence of genetic mutations, and the prevalence of consanguineous marriage. Cell and gene therapy clinical trial services address the rising incidence of genetic diseases by encouraging the development of novel treatments, tailoring therapies to individual patients, accelerating the translation of research into clinical practice, and expanding the options available to patients suffering from genetic disorders. For instance, in July 2022, according to the Cystic Fibrosis (CF) Foundation, a US-based non-profit organization, there had been an upsurge in the number of people with cystic fibrosis. In 2022, cystic fibrosis affected almost 40,000 children and adults in the United States, and over 105,000 people worldwide have been diagnosed. Therefore, the rising incidence of genetic disease is driving the growth of the cell and gene therapy clinical trial services industry.

Who Are The Major Players In The Global Cell And Gene Therapy Clinical Trial Services Market?

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.

What Are The Key Trends Of The Global Cell And Gene Therapy Clinical Trial Services Market? Innovative Solutions In Cell And Gene Therapy Clinical Trial Services Market

Major companies operating in the cell and gene therapy clinical trial services market are focusing their efforts on introducing advanced technology with customer relationship management system technology, to improve efficiency, and gain a competitive edge in the market. The customer relationship management system utilized by cell and gene therapy clinical trial services streamlines and coordinates interactions with trial participants, healthcare providers, and other stakeholders throughout the clinical trial process. For instance, in April 2023, AmerisourceBergen Corporation, a US-based healthcare company, launched the Cell and Gene Therapy (CGT) Integration Hub, a platform that aims to increase connectivity and streamline processes throughout the cell and gene therapy treatment pathway. This platform is backed by AmerisourceBergen's customer relationship management (CRM) system and attempts to streamline the path-to-care process, in part by giving physicians and patient services teams better visibility across the therapy development and delivery process. The CGT Integration Hub, which includes features such as expedited benefits investigation, real-time status tracking, and proactive alerts, aims to simplify care coordination, minimize barriers, and improve the entire patient and provider experience when delivering cell and gene therapies.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Cell And Gene Therapy Clinical Trial Services Market? Kyowa Kirin Co. Ltd. Expands Genetic Medicine Portfolio With Orchard Therapeutics Acquisition

In January 2024, Kyowa Kirin Co. Ltd., a Japan-based pharmaceutical company, acquired Orchard Therapeutics Limited for an undisclosed amount. Through this acquisition, Kyowa Kirin aims to enhance its focus on addressing the unmet medical needs of individuals with genetic and severe diseases by leveraging Orchard's expertise in developing and commercializing gene therapies for rare diseases. Orchard Therapeutics Limited is a UK-based biotechnology company primarily dedicated to the research, development, and commercialization of gene therapies for rare diseases.

What Is The Regional Outlook For The Global Cell And Gene Therapy Clinical Trial Services Market?

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell And Gene Therapy Clinical Trial Services Market?

The cell and gene therapy clinical trial services market includes revenues earned by providing services, such as regulatory pathways navigation, logistics management, patient retention strategy management, and biomarker analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cell And Gene Therapy Clinical Trial Services Industry?

The cell and gene therapy clinical trial services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell and gene therapy clinical trial services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cell And Gene Therapy Clinical Trial Services Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $4.18 billion
Revenue Forecast In 2034 $6.02 billion
Growth Rate CAGR of 9.5% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Service: Clinical Trial Design And Planning, Supply And Logistic Services, Regulatory Affairs And Compliance, Data Management And Biostatics, Site Management And Monitoring, Other Services
2) By Therapy Type: Gene Therapy, Cell Therapy, Gene Modified Cell Therapy
3) By Indication: Oncology, Hematology, Metabolic Disorders, Infectious Diseases, Neurology, Cardiovascular Diseases, Musculoskeletal Disorders, Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Academic And Research Institutes, Other End-Users Subsegments: 1) By Clinical Trial Design And Planning: Protocol Development, Trial Feasibility Studies, Trial Design Consultation, Patient Recruitment And Enrollment Strategy, Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management, Cold Chain Logistics, Packaging And Labeling Services, Transportation And Distribution Of Biological Samples, Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting, Regulatory Submission And Documentation, Compliance With GMP (Good Manufacturing Practices), Regulatory Pathway Consultation, Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM), Statistical Analysis And Reporting, Clinical Data Monitoring, Data Integration And Validation, Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation, Clinical Monitoring And Site Visits, Patient Recruitment And Retention, Site Training And Support, Site Performance Monitoring 6) By Other Services: Patient Advocacy And Engagement, Real-World Evidence (RWE) Studies, Post-Trial Services, Medical Writing And Documentation, Clinical Trial Auditing And Inspection
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cell And Gene Therapy Clinical Trial Services Market Characteristics

3. Cell And Gene Therapy Clinical Trial Services Market Trends And Strategies

4. Cell And Gene Therapy Clinical Trial Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cell And Gene Therapy Clinical Trial Services Growth Analysis And Strategic Analysis Framework

5.1. Global Cell And Gene Therapy Clinical Trial Services PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cell And Gene Therapy Clinical Trial Services Market Growth Rate Analysis

5.4. Global Cell And Gene Therapy Clinical Trial Services Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cell And Gene Therapy Clinical Trial Services Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cell And Gene Therapy Clinical Trial Services Total Addressable Market (TAM)

6. Cell And Gene Therapy Clinical Trial Services Market Segmentation

6.1. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Trial Design And Planning

Supply And Logistic Services

Regulatory Affairs And Compliance

Data Management And Biostatics

Site Management And Monitoring

Other Services

6.2. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Gene Therapy

Cell Therapy

Gene Modified Cell Therapy

6.3. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncology

Hematology

Metabolic Disorders

Infectious Diseases

Neurology

Cardiovascular Diseases

Musculoskeletal Disorders

Other Indications

6.4. Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biotechnology Companies

Contract Research Organizations

Academic And Research Institutes

Other End-Users

6.5. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protocol Development

Trial Feasibility Studies

Trial Design Consultation

Patient Recruitment And Enrollment Strategy

Risk-Based Monitoring Plans

6.6. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistic Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Trial Supply Chain Management

Cold Chain Logistics

Packaging And Labeling Services

Transportation And Distribution Of Biological Samples

Customs And Import/Export Services

6.7. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Affairs And Compliance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Regulatory Strategy And Consulting

Regulatory Submission And Documentation

Compliance With GMP (Good Manufacturing Practices)

Regulatory Pathway Consultation

Clinical Trial Applications (CTAs)

6.8. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Clinical Data Management (CDM)

Statistical Analysis And Reporting

Clinical Data Monitoring

Data Integration And Validation

Electronic Data Capture (EDC) Solutions

6.9. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Site Selection And Initiation

Clinical Monitoring And Site Visits

Patient Recruitment And Retention

Site Training And Support

Site Performance Monitoring

6.10. Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Patient Advocacy And Engagement

Real-World Evidence (RWE) Studies

Post-Trial Services

Medical Writing And Documentation

Clinical Trial Auditing And Inspection

7. Cell And Gene Therapy Clinical Trial Services Market Regional And Country Analysis

7.1. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market

8.1. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cell And Gene Therapy Clinical Trial Services Market

9.1. China Cell And Gene Therapy Clinical Trial Services Market Overview

9.2. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cell And Gene Therapy Clinical Trial Services Market

10.1. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cell And Gene Therapy Clinical Trial Services Market

11.1. Japan Cell And Gene Therapy Clinical Trial Services Market Overview

11.2. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cell And Gene Therapy Clinical Trial Services Market

12.1. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cell And Gene Therapy Clinical Trial Services Market

13.1. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cell And Gene Therapy Clinical Trial Services Market

14.1. South Korea Cell And Gene Therapy Clinical Trial Services Market Overview

14.2. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cell And Gene Therapy Clinical Trial Services Market

15.1. Western Europe Cell And Gene Therapy Clinical Trial Services Market Overview

15.2. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cell And Gene Therapy Clinical Trial Services Market

16.1. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cell And Gene Therapy Clinical Trial Services Market

17.1. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cell And Gene Therapy Clinical Trial Services Market

18.1. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cell And Gene Therapy Clinical Trial Services Market

19.1. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cell And Gene Therapy Clinical Trial Services Market

20.1. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market

21.1. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market Overview

21.2. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cell And Gene Therapy Clinical Trial Services Market

22.1. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cell And Gene Therapy Clinical Trial Services Market

23.1. North America Cell And Gene Therapy Clinical Trial Services Market Overview

23.2. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cell And Gene Therapy Clinical Trial Services Market

24.1. USA Cell And Gene Therapy Clinical Trial Services Market Overview

24.2. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cell And Gene Therapy Clinical Trial Services Market

25.1. Canada Cell And Gene Therapy Clinical Trial Services Market Overview

25.2. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cell And Gene Therapy Clinical Trial Services Market

26.1. South America Cell And Gene Therapy Clinical Trial Services Market Overview

26.2. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cell And Gene Therapy Clinical Trial Services Market

27.1. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cell And Gene Therapy Clinical Trial Services Market

28.1. Middle East Cell And Gene Therapy Clinical Trial Services Market Overview

28.2. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cell And Gene Therapy Clinical Trial Services Market

29.1. Africa Cell And Gene Therapy Clinical Trial Services Market Overview

29.2. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape And Company Profiles

30.1. Cell And Gene Therapy Clinical Trial Services Market Competitive Landscape

30.2. Cell And Gene Therapy Clinical Trial Services Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Sharp Services LLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. IQVIA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

30.2.5. ICON plc Overview, Products and Services, Strategy and Financial Analysis

31. Cell And Gene Therapy Clinical Trial Services Market Other Major And Innovative Companies

31.1. Syneos Health Inc.

31.2. Catalent Pharma Solutions Inc.

31.3. Charles River Laboratories International Inc.

31.4. Parexel International Corporation

31.5. PRA Health Sciences Inc.

31.6. Covance Inc.

31.7. Medpace Holdings Inc.

31.8. BioClinica Inc.

31.9. Precision Medicine Group LLC

31.10. Worldwide Clinical Trials LLC

31.11. Clinigen Group plc

31.12. Evidera Inc.

31.13. Advarra LLC

31.14. Veristat LLC

31.15. Clinipace Inc.

32. Global Cell And Gene Therapy Clinical Trial Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cell And Gene Therapy Clinical Trial Services Market

34. Recent Developments In The Cell And Gene Therapy Clinical Trial Services Market

35. Cell And Gene Therapy Clinical Trial Services Market High Potential Countries, Segments and Strategies

35.1 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Countries Offering Most New Opportunities

35.2 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Segments Offering Most New Opportunities

35.3 Cell And Gene Therapy Clinical Trial Services Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistic Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Affairs And Compliance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Thermo Fisher Scientific Inc. Financial Performance
  • Table 82: Sharp Services LLC Financial Performance
  • Table 83: IQVIA Financial Performance
  • Table 84: Laboratory Corporation of America Holdings Financial Performance
  • Table 85: ICON plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cell And Gene Therapy Clinical Trial Services Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Clinical Trial Design And Planning, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Supply And Logistic Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Regulatory Affairs And Compliance, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Data Management And Biostatistics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Site Management And Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cell And Gene Therapy Clinical Trial Services Market, Sub-Segmentation Of Other Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Cell And Gene Therapy Clinical Trial Services Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Cell And Gene Therapy Clinical Trial Services Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 82: Sharp Services LLC Financial Performance
  • Figure 83: IQVIA Financial Performance
  • Figure 84: Laboratory Corporation of America Holdings Financial Performance
  • Figure 85: ICON plc Financial Performance

Global Large And Small-Scale Bioprocessing Market Projected to Reach $108.81 Billion by 2029 at a CAGR of 12.6%

Read More About Global Large And Small-Scale Bioprocessing Market Projected to Reach $108.81 Billion by 2029 at a CAGR of 12.6%

$19.28 Billion Forecast for Large Molecule Bioanalytical Technologies Market by 2029, Backed by Demand and Innovation

Read More About $19.28 Billion Forecast for Large Molecule Bioanalytical Technologies Market by 2029, Backed by Demand and Innovation

Leadless Pacemakers Market Forecast Reaching $1.17 Billion by 2029 at 14.8% CAGR

Read More About Leadless Pacemakers Market Forecast Reaching $1.17 Billion by 2029 at 14.8% CAGR

Levothyroxine Sodium Market Valuation Expected To Reach $4.78 Billion By 2029, Growing At A Rate Of 4.1%

Read More About Levothyroxine Sodium Market Valuation Expected To Reach $4.78 Billion By 2029, Growing At A Rate Of 4.1%

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Retail Digital Transformation Global Market Report 2025 – By Accessibility (Mobile Application, Website), By Technology (Cloud Computing, Big Data, Artificial intelligence, Internet Of Things (IoT), Augmented Reality (AR...

View Report

Generative AI In Creative Industries Global Market Report 2025 – By Type (Text-To-Image Generation, Image-To-Image Generation, Music Generation, Video Generation, 3D Modeling and Animation), By Deployment Mode (On-Premis...

View Report

Gene Therapy Global Market Report 2025 – By Gene Therapy Type (Germline Therapy, Somatic Cell Therapy), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncology, Orphan Disease, Knee Osteoarthritis, Neurologi...

View Report

Cell Therapy Global Market Report 2025 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous ...

View Report

Cell Therapy Technologies Global Market Report 2025 – By Product (Consumables, Equipment, Systems And Software), By Cell Type (T-Cells, Stem Cells, Other Cells), By Process (Cell Processing, Cell Preservation, Distributi...

View Report

Nucleic Acid Based Gene Therapy Global Market Report 2025 – By Technology (Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies), By App...

View Report

Platelet Aggregation Devices Global Market Report 2025 – By Product (Reagents, Systems, Consumables And Accessories), By Type ( Four Channel, Dual Channel, Eight Channel), By Technology (Optical, Impedance, Other Technol...

View Report

Frequently Asked Questions

Cell and gene therapy clinical trial services refer to specialized services offered by contract research organizations (CROs) or clinical trial management corporations to facilitate the design, implementation, and management of clinical trials for cell and gene therapies. These services, which range from protocol design and patient recruiting to regulatory compliance and data administration, serve as the foundation for trials to progress smoothly, ensuring precision, efficacy, and adherence to high standards. For further insights on this market, request a sample here

The market major growth driver - Role Of Cell And Gene Therapy Trials In Tackling Genetic Diseases. For further insights on this market, request a sample here

The cell and gene therapy clinical trial services market size has grown rapidly in recent years. It will grow from $3.79 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to the increased prevalence of chronic diseases, increased demand for effective treatments for rare genetic disorders, increased government funding for research in regenerative medicine, increased understanding of molecular mechanisms underlying various diseases, and increased awareness of the potential of personalized medicine. The cell and gene therapy clinical trial services market size is expected to see strong growth in the next few years. It will grow to " $6.02 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to increasing global incidence of genetic and auto-immune diseases, rising public and private sector funding for gene therapy research, growing adoption of novel technologies, and a rise in the number of genetic defects. Major trends in the forecast period include the adoption of AI, the adoption of machine learning, the adoption of personalized medicine, technological advancements, and gene therapies. For further insights on this market, request a sample here

The cell and gene therapy clinical trial servicesmarket covered in this report is segmented –
1) By Service: Clinical Trial Design And Planning; Supply And Logistic Services; Regulatory Affairs And Compliance; Data Management And Biostatics; Site Management And Monitoring; Other Services
2) By Therapy Type: Gene Therapy; Cell Therapy; Gene Modified Cell Therapy
3) By Indication: Oncology; Hematology; Metabolic Disorders; Infectious Diseases; Neurology; Cardiovascular Diseases; Musculoskeletal Disorders; Other Indications
4) By End-Use: Pharmaceutical And Biotechnology Companies; Contract Research Organizations; Academic And Research Institutes; Other End-Users Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development; Trial Feasibility Studies; Trial Design Consultation; Patient Recruitment And Enrollment Strategy; Risk-Based Monitoring Plans
2) By Supply And Logistic Services: Clinical Trial Supply Chain Management; Cold Chain Logistics; Packaging And Labeling Services; Transportation And Distribution Of Biological Samples; Customs And Import/Export Services
3) By Regulatory Affairs And Compliance: Regulatory Strategy And Consulting; Regulatory Submission And Documentation; Compliance With GMP (Good Manufacturing Practices); Regulatory Pathway Consultation; Clinical Trial Applications (CTAs)
4) By Data Management And Biostatistics: Clinical Data Management (CDM); Statistical Analysis And Reporting; Clinical Data Monitoring; Data Integration And Validation; Electronic Data Capture (EDC) Solutions
5) By Site Management And Monitoring: Site Selection And Initiation; Clinical Monitoring And Site Visits; Patient Recruitment And Retention; Site Training And Support; Site Performance Monitoring
6) By Other Services: Patient Advocacy And Engagement; Real-World Evidence (RWE) Studies; Post-Trial Services; Medical Writing And Documentation; Clinical Trial Auditing And Inspection For further insights on this market, request a sample here

North America was the largest region in the cell and gene therapy clinical trial services market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the cell and gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the cell and gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, IQVIA, Laboratory Corporation of America Holdings, ICON plc, Syneos Health Inc., Catalent Pharma Solutions Inc., Charles River Laboratories International Inc., Parexel International Corporation, PRA Health Sciences Inc., Covance Inc., Medpace Holdings Inc., BioClinica Inc., Precision Medicine Group LLC, Worldwide Clinical Trials LLC, Clinigen Group plc, Evidera Inc., Advarra LLC, Veristat LLC, Clinipace Inc., Celonic AG, Cromsource Inc., Novotech Pty Ltd., MedSource Holdings Inc., Frontage Laboratories Inc. . For further insights on this market, request a sample here.

Major trends in this market include Innovative Solutions In Cell And Gene Therapy Clinical Trial Services Market. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cell And Gene Therapy Clinical Trial Services Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon